Furthermore, the overexpression of PTGS2 was able to activate VEGF for tumor growth and diffusion [71], and EZ from CBC could treat liver cancer by inhibiting PTGS2 and VEGF [52]. This evidence concerns the gene VEGFA and liver cancer.